Pathophysiology guided treatment of nonalcoholic steatohepatitis - Wikidata - awgldk - TriplyDB

Pathophysiology guided treatment of nonalcoholic steatohepatitis

Pathophysiology guided treatment of nonalcoholic steatohepatitis

http://www.wikidata.org/entity/Q26827117

about

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals Recent advances in understanding/management of non-alcoholic steatohepatitis.Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial Pathophysiology of NASH: perspectives for a targeted treatment.Influence of hepatic parenchymal histology on outcome following right hepatic trisectionectomy.Novel therapeutic targets for nonalcoholic fatty liver disease.Steatosis in the liver.Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.

P2860

Q22299426-4ECFD3BB-4120-49C1-8E5D-148BD18460F0 Q28085689-A179A553-3CCD-4CFD-A0B6-1024A1F71B41 Q33599564-CC57CE48-C9A8-4CE7-9EDC-C85EEE89B82B Q34415002-F743A805-B6DB-4ACE-82BD-F3C05625CB5C Q37515585-306B0B40-CC8D-4388-93BF-8FACF3C3337F Q37699476-2F7BAEAE-05ED-4C38-83F1-5E071A74B208 Q38038107-B3E0CAD1-9EAE-476E-89F0-0500BD6ACB9E Q38100206-CF110263-5789-43C1-9343-A075206AB0A7 Q38165140-13F6CB8A-1980-4A7F-9421-E71D520DC632 Q42347122-1C9F8D01-57BF-4245-9CFE-01C15AF5289C

P2860

Pathophysiology guided treatment of nonalcoholic steatohepatitis

http://www.wikidata.org/entity/Q26827117

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@ast

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@en

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@nl

type

label

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@ast

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@en

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@nl

prefLabel

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@ast

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@en

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@nl

P1433

Q26827117-4788B61D-EE18-42E1-9318-F8911EB356DD

P1476

Q26827117-E09C433F-C381-4AB4-A757-1EB71E2BAFDF

P2093

Q26827117-091DC14E-43BA-49B2-9BF9-165A3D720E8C

Q26827117-54DF7215-750E-4059-83C8-C1FA29F686EB

P2860

Q26827117-02DA39B4-0333-45D1-B010-830353BE138B

Q26827117-0C7DF8D9-42AC-4276-AB4D-8247699C1505

Q26827117-1BCE8F3D-1E04-49D9-9981-D0CC796EC1B1

Q26827117-24CA0F33-D567-4042-832F-853D6A53A0FC

Q26827117-2E9C6D6F-4907-4413-963B-6E7252C58ACC

Q26827117-2FC7FBF1-13A8-4577-B724-5D1D9A6F0E15

Q26827117-31A53894-CA52-4F0A-B7BB-54442627ACA5

Q26827117-42412520-3E43-4D5B-983D-4C9FC340EA6A

Q26827117-49DD9E4D-29F6-4D2B-AA34-1754AB4D7CF5

Q26827117-49F4878D-B09D-4CFA-8613-4A46C79B0366

P304

Q26827117-EB46AC91-E059-4A84-9B61-5EF3C460E9D8

P31

Q26827117-F55D7C58-4237-40DC-91A7-002238E98AEB

P356

Q26827117-F78BC363-0039-4C15-881E-1A4C680C77F5

P407

Q26827117-DAE61EFB-DA9C-4B55-B2E9-FC47931939FB

P478

Q26827117-296115EE-AFF5-4990-91A8-0669FE87FD1E

P577

Q26827117-A899C84A-1169-44EE-9B4B-C86E778D777A

P698

Q26827117-87A9A6BD-3CD8-4F1E-869B-FD227F267572

P921

Q26827117-6513BB95-FC1A-4630-8372-07588AA8EFA6

Q26827117-C6ECCDD2-E710-4B15-A74C-89964EEA55DD

P932

Q26827117-8D6355E0-FC27-44FE-9ECA-C9B90DD52207

P356

J.1440-1746.2011.07018.X

P1433

Journal of Gastroenterology and Hepatology

P1476

Pathophysiology guided treatment of nonalcoholic steatohepatitis

@en

P2093

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Tuyet A T Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.

Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA.

P304

58-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1746.2011.07018.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

27 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22320918

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

Steatohepatitis

P932

4900150

http://www.w3.org/2001/XMLSchema#string